Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1) announced Monday that the US Food and Drug Administration (FDA) had positive things to say during a review of the preclinical data package and clinical development plan for its drug ARDS-003 as a treatment for the coronavirus (COVID-19). The review was conducted within the framework of the Coronavirus Treatment Acceleration Program (CTAP), the FDA’s expedited process for investigational therapies to treat COVID-19 patients, the company said. The regulatory body agreed that the animal toxicology and safety data indicates that ARDS-003 is safe for human use, and it approved the sample size, safety procedures and duration of treatment in severe COVID-19 patients. Having received feedback, the company plans to file an investigational new drug application to initiate a clinical trial.
Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) (FRA:MMQ) published new data from its MDMA study on Monday that revealed the dosage can be optimized based on known predictors like a person’s age and weight. The study, which took place at the University Hospital Basel Liechti Lab, in Basel, Switzerland, provided the first scientific data for predicting responses to MDMA and optimizing dosing. MindMed told investors that personally-tailored dosing may maximize the potential beneficial therapeutic effects while reducing adverse responses when treating medical conditions.
PlantX Life Inc (CSE:VEGA) (OTCQB:PLXTF) (FRA:WNT1) revealed that the Canadian Food Inspection Agency (CFIA) has granted the company a license to import packaged plant-based products from the United States to Canada. The Vancouver, British Columbia-based company, which is a one-stop destination for all things plant based, said the import license complements PlantX’s success in creating a diverse infrastructure of partnerships with plant-based vendors across the US. “We are extremely pleased to be at the forefront of bringing US-manufactured plant-based goods to Canada,” said PlantX CEO Julia Frank.
PsyBio Therapeutics Corp (CVE:PSYB) announced Monday the appointment of Dr Michael Spigarelli as chief medical officer to lead the ongoing development of the company’s drug discovery platform technology. Dr Spigarelli brings his extensive expertise in research and development of biopharmaceuticals including the clinical and regulatory strategy for numerous mental health therapeutics and other conditions, the company said in a statement. He will provide PsyBio with decades of clinical product development experience, including clinical trial design and execution, data analytics and presentation, regulatory approval, quality control and GXP project management. Before joining PsyBio Therapeutics, Dr Spigarelli served as chief medical officer for Lumen Bioscience.
GoviEx Uranium Inc (CVE:GXU) (OTCQB:GVXXF) (FRA:7GU) has filed a technical report titled “An Updated Pre-Feasibility Study for the Madaouela Project, Niger,” dated April 5, which supports the disclosure in its news release dated February 18. Highlights include: open pit mining in the early years with capital expenditures reduced by 15% and operationing expenses down by 20%; grid level electrical power within the Madaouela Project boundary; potential to service debt of US$110 million to $180 million; ability to fast track feasibility study in 2021 to target rapid development.
American Resources Corporation (NASDAQ:AREC) announced that American Acquisition Opportunity Inc, the company’s sponsored special purpose acquisition company (SPAC) in which it has an indirect investment, has closed the issuance of an additional 506,002 units pursuant to the partial exercise of the underwriter’s over-allotment option in connection with the SPAC’s initial public offering. The units are listed on the NASDAQ under the ticker symbol ‘AMAOU’. Each unit consists of one share of the company’s Class A common stock and one-half of one redeemable warrant, entitling the holder to purchase one share of Class A common stock at a price of $11.50 per share. American Resources said the SPAC is targeting land and resource holding companies, with the potential to create, support, and/or innovate for the new economy.
Biocept Inc (NASDAQ:BIOC) announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees. The options have an exercise price of $5.09 per share, a grant date of March 31 and were granted as inducements material to the new employees entering into employment with Biocept in accordance with Nasdaq Listing Rule 5635(c)(4).
HempFusion Wellness Inc (TSE:CBD.U)(OTCMKTS:CBDHF) told shareholders Monday that its “future is bright” as it heads into 2021. “The company has built a strong foundation throughout a challenging 2020,” Denver-based HempFusion wrote in a shareholder update. “After the completion of a successful IPO, the Company remains focused on executing it’s five channel strategy driving significant revenue growth across domestic and international markets in 2021 and beyond. We remain hyper focused on the long game.”
Victory Resources Corporation (CSE:VR) (OTCMKTS:VRCFF) (FRA:VR62) said it has completed site preparations for a short-hole drill program on the company’s recently-optioned Loner Property in Nevada. Victory Resources noted the seven to ten short-hole diamond drill program will test the historically mined vein area and investigate wall rock mineralization.
Virtual Investor Conferences, the leading proprietary investor conference series today announced that the presentations from the March Extractive Industry lnvestor Conference are now available for on-demand viewing. The company presentations will be available for 90 days, and interested parties can register/login to view them here: https://bit.ly/2PllJGf
BioSig Technologies Inc (NASDAQ:BSGM) announced that its CEO Ken Londoner will provide a corporate overview and business update at the 20th Annual Needham Virtual Healthcare Conference on Monday, April 12th, 2021 at 3 PM ET. BioSig’s PURE EP System is an advanced signal acquisition and processing platform that seeks to set a new standard in electrophysiology. The system provides essential diagnostic signals with high clinical value in all types of cardiac ablations. More than 40 physicians have completed over 600 patient cases with the PURE EP System across 8 clinical sites. For parties interested in scheduling a one-on-one meeting with BioSig management, please contact the conference coordinators at [email protected]
CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, said it has completed an additional potentially non-dilutive convertible debt offering with an institutional investor, which provides “$25 million of immediately available capital.” The note has a two-year maturity, bears interest at the rate of 10% per annum and is secured by assets belonging to the company, excluding its intellectual property. In a statement, CytoDyn CEO Nader Pourhassan said: “We are very pleased with the institution’s demonstration of confidence and their understanding of leronlimab’s positioning on its regulatory trajectory. This infusion of capital will help ensure we have sufficient quantities of leronlimab available upon any potential approvals for COVID-19 treatment.”
QC Copper and Gold Inc (CVE:QCCU) (OTCMKTS:QCCUF) said it has signed an agreement to buy a 50% ownership interest in the Roger Gold-Copper project located in Quebec’s Chibougamau District from Pasofino Gold Ltd (CVE:VEIN) (OTCMKTS:EFRGF) (FRA:N07). The company will pay a total consideration of C$2 million for the property, consisting of $1 million in cash and 5.5 million QC Copper shares.
Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) announced a partnership Monday to deploy its Safe Entry Station units in partnership with event management firm Juiceworks Exhibits and marketing software company Connectus Global. The Safe Entry Systems rely on military-grade multispectral cameras paired with proprietary, clinically-based artificial intelligence algorithms to check for multiple symptoms associated with the coronavirus (COVID-19). With this partnership, Predictmedix will make its customizable Safe Entry Stations available to Connectus Global’s clients.
Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1) announced that the US Food and Drug Administration (FDA) had positive things to say during a review of the preclinical data package and clinical development plan for its drug ARDS-003 as a treatment for the coronavirus (COVID-19). ARDS-003 is formulated to treat hyperinflammatory conditions, such as those seen in patients suffering from COVID-19 viral infections. Having heard from the regulatory body, the company plans to file an investigational new drug application to initiate a clinical trial.
Loop Insights Inc (CVE:MTRX) (OTCQB:RACMF) announced it has joined the Sovrin Foundation, an open-source, open-standards technology platform for digital identity. Built on a public blockchain, Loop said the Sovrin Ledger protects personal information while giving control of personal data back to the individuals. The company joins over 70 leading tech organizations around the world including Cisco, T-Mobile, and NEC that have committed computing power and resources to strengthen the Sovrin Network.
Real Luck Group Ltd (CVE:LUCK) (OTCMKTS:LUKEF), doing business as Luckbox, has received approval to trade on the OTCQB Venture Market starting Monday. The company’s common shares will trade under the symbol “LUKEF” on the New York-based exchange. Real Luck Group‘s commons shares will continue trading on the TSX Venture Exchange under the symbol “LUCK”.
Thor Explorations Ltd (CVE:THX) (OTCMKTS:THXPF) has signed an agreement with Barrick Gold Corp (NYSE:GOLD) (TSE:ABX) (FRA:ABR) that terminates the 2015 earn-in agreement between Thor and Acacia Mining PLC on the Central Hounde project in southwestern Burkina Faso. Following the signing of the agreement with Acacia (which Barrick has acquired), Thor said it has acquired Barrick’s 51% ownership of the project in exchange for a 1% net smelter royalty. Thor now holds 100% of the project.
Story by ProactiveInvestors
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 888-809-8385 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
pathogens and gives you more
energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video)
Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.